 | • レポートコード：MRC2-11QY04598 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は帯状疱疹治療のグローバル市場について調査・分析したレポートです。種類別（経口、錠剤）市場規模、用途別（クリニック、病院、診断センター、在宅ケア設定）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別帯状疱疹治療の競争状況、市場シェア ・世界の帯状疱疹治療市場：種類別市場規模 2015年-2020年（経口、錠剤） ・世界の帯状疱疹治療市場：種類別市場規模予測 2021年-2026年（経口、錠剤） ・世界の帯状疱疹治療市場：用途別市場規模 2015年-2020年（クリニック、病院、診断センター、在宅ケア設定） ・世界の帯状疱疹治療市場：用途別市場規模予測 2021年-2026年（クリニック、病院、診断センター、在宅ケア設定） ・北米の帯状疱疹治療市場分析：米国、カナダ ・ヨーロッパの帯状疱疹治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの帯状疱疹治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の帯状疱疹治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの帯状疱疹治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Astellas Pharma、Foamix、Novartis、Roche、GlaxoSmithKline、Epiphany Biosciences、Merck、Beijing Minhai Biotechnology、GeneOne Life Science、NAL Pharmaceuticals、TSRL ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Shingles is a viral disease characterized by a painful skin rash with blisters in a localized area.
The shingles treatment market is expected to witness a high growth over the forecast period owing to the increasing prevalence of shingles.
Market Analysis and Insights: Global Shingles Treatments Market
The global Shingles Treatments market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Shingles Treatments Scope and Market Size
Shingles Treatments market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Shingles Treatments market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Astellas Pharma
Foamix
Novartis
Roche
GlaxoSmithKline
Epiphany Biosciences
Merck
Beijing Minhai Biotechnology
GeneOne Life Science
NAL Pharmaceuticals
TSRL
Market segment by Type, the product can be split into
Oral
Tablets
Market segment by Application, split into
Clinics
Hospitals
Diagnostic Centres
Home Care Settings
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Shingles Treatments Revenue
1.4 Market by Type
1.4.1 Global Shingles Treatments Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Oral
1.4.3 Tablets
1.5 Market by Application
1.5.1 Global Shingles Treatments Market Share by Application: 2020 VS 2026
1.5.2 Clinics
1.5.3 Hospitals
1.5.4 Diagnostic Centres
1.5.5 Home Care Settings
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Shingles Treatments Market Perspective (2015-2026)
2.2 Global Shingles Treatments Growth Trends by Regions
2.2.1 Shingles Treatments Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Shingles Treatments Historic Market Share by Regions (2015-2020)
2.2.3 Shingles Treatments Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Shingles Treatments Market Growth Strategy
2.3.6 Primary Interviews with Key Shingles Treatments Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Shingles Treatments Players by Market Size
3.1.1 Global Top Shingles Treatments Players by Revenue (2015-2020)
3.1.2 Global Shingles Treatments Revenue Market Share by Players (2015-2020)
3.1.3 Global Shingles Treatments Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Shingles Treatments Market Concentration Ratio
3.2.1 Global Shingles Treatments Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Shingles Treatments Revenue in 2019
3.3 Shingles Treatments Key Players Head office and Area Served
3.4 Key Players Shingles Treatments Product Solution and Service
3.5 Date of Enter into Shingles Treatments Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Shingles Treatments Historic Market Size by Type (2015-2020)
4.2 Global Shingles Treatments Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Shingles Treatments Market Size by Application (2015-2020)
5.2 Global Shingles Treatments Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Shingles Treatments Market Size (2015-2020)
6.2 Shingles Treatments Key Players in North America (2019-2020)
6.3 North America Shingles Treatments Market Size by Type (2015-2020)
6.4 North America Shingles Treatments Market Size by Application (2015-2020)
7 Europe
7.1 Europe Shingles Treatments Market Size (2015-2020)
7.2 Shingles Treatments Key Players in Europe (2019-2020)
7.3 Europe Shingles Treatments Market Size by Type (2015-2020)
7.4 Europe Shingles Treatments Market Size by Application (2015-2020)
8 China
8.1 China Shingles Treatments Market Size (2015-2020)
8.2 Shingles Treatments Key Players in China (2019-2020)
8.3 China Shingles Treatments Market Size by Type (2015-2020)
8.4 China Shingles Treatments Market Size by Application (2015-2020)
9 Japan
9.1 Japan Shingles Treatments Market Size (2015-2020)
9.2 Shingles Treatments Key Players in Japan (2019-2020)
9.3 Japan Shingles Treatments Market Size by Type (2015-2020)
9.4 Japan Shingles Treatments Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Shingles Treatments Market Size (2015-2020)
10.2 Shingles Treatments Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Shingles Treatments Market Size by Type (2015-2020)
10.4 Southeast Asia Shingles Treatments Market Size by Application (2015-2020)
11 India
11.1 India Shingles Treatments Market Size (2015-2020)
11.2 Shingles Treatments Key Players in India (2019-2020)
11.3 India Shingles Treatments Market Size by Type (2015-2020)
11.4 India Shingles Treatments Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Shingles Treatments Market Size (2015-2020)
12.2 Shingles Treatments Key Players in Central & South America (2019-2020)
12.3 Central & South America Shingles Treatments Market Size by Type (2015-2020)
12.4 Central & South America Shingles Treatments Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Astellas Pharma
13.1.1 Astellas Pharma Company Details
13.1.2 Astellas Pharma Business Overview
13.1.3 Astellas Pharma Shingles Treatments Introduction
13.1.4 Astellas Pharma Revenue in Shingles Treatments Business (2015-2020))
13.1.5 Astellas Pharma Recent Development
13.2 Foamix
13.2.1 Foamix Company Details
13.2.2 Foamix Business Overview
13.2.3 Foamix Shingles Treatments Introduction
13.2.4 Foamix Revenue in Shingles Treatments Business (2015-2020)
13.2.5 Foamix Recent Development
13.3 Novartis
13.3.1 Novartis Company Details
13.3.2 Novartis Business Overview
13.3.3 Novartis Shingles Treatments Introduction
13.3.4 Novartis Revenue in Shingles Treatments Business (2015-2020)
13.3.5 Novartis Recent Development
13.4 Roche
13.4.1 Roche Company Details
13.4.2 Roche Business Overview
13.4.3 Roche Shingles Treatments Introduction
13.4.4 Roche Revenue in Shingles Treatments Business (2015-2020)
13.4.5 Roche Recent Development
13.5 GlaxoSmithKline
13.5.1 GlaxoSmithKline Company Details
13.5.2 GlaxoSmithKline Business Overview
13.5.3 GlaxoSmithKline Shingles Treatments Introduction
13.5.4 GlaxoSmithKline Revenue in Shingles Treatments Business (2015-2020)
13.5.5 GlaxoSmithKline Recent Development
13.6 Epiphany Biosciences
13.6.1 Epiphany Biosciences Company Details
13.6.2 Epiphany Biosciences Business Overview
13.6.3 Epiphany Biosciences Shingles Treatments Introduction
13.6.4 Epiphany Biosciences Revenue in Shingles Treatments Business (2015-2020)
13.6.5 Epiphany Biosciences Recent Development
13.7 Merck
13.7.1 Merck Company Details
13.7.2 Merck Business Overview
13.7.3 Merck Shingles Treatments Introduction
13.7.4 Merck Revenue in Shingles Treatments Business (2015-2020)
13.7.5 Merck Recent Development
13.8 Beijing Minhai Biotechnology
13.8.1 Beijing Minhai Biotechnology Company Details
13.8.2 Beijing Minhai Biotechnology Business Overview
13.8.3 Beijing Minhai Biotechnology Shingles Treatments Introduction
13.8.4 Beijing Minhai Biotechnology Revenue in Shingles Treatments Business (2015-2020)
13.8.5 Beijing Minhai Biotechnology Recent Development
13.9 GeneOne Life Science
13.9.1 GeneOne Life Science Company Details
13.9.2 GeneOne Life Science Business Overview
13.9.3 GeneOne Life Science Shingles Treatments Introduction
13.9.4 GeneOne Life Science Revenue in Shingles Treatments Business (2015-2020)
13.9.5 GeneOne Life Science Recent Development
13.10 NAL Pharmaceuticals
13.10.1 NAL Pharmaceuticals Company Details
13.10.2 NAL Pharmaceuticals Business Overview
13.10.3 NAL Pharmaceuticals Shingles Treatments Introduction
13.10.4 NAL Pharmaceuticals Revenue in Shingles Treatments Business (2015-2020)
13.10.5 NAL Pharmaceuticals Recent Development
13.11 TSRL
10.11.1 TSRL Company Details
10.11.2 TSRL Business Overview
10.11.3 TSRL Shingles Treatments Introduction
10.11.4 TSRL Revenue in Shingles Treatments Business (2015-2020)
10.11.5 TSRL Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Shingles Treatments Key Market Segments
Table 2. Key Players Covered: Ranking by Shingles Treatments Revenue
Table 3. Ranking of Global Top Shingles Treatments Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Shingles Treatments Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Oral
Table 6. Key Players of Tablets
Table 7. Global Shingles Treatments Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Shingles Treatments Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Shingles Treatments Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Shingles Treatments Market Share by Regions (2015-2020)
Table 11. Global Shingles Treatments Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Shingles Treatments Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Shingles Treatments Market Growth Strategy
Table 17. Main Points Interviewed from Key Shingles Treatments Players
Table 18. Global Shingles Treatments Revenue by Players (2015-2020) (Million US$)
Table 19. Global Shingles Treatments Market Share by Players (2015-2020)
Table 20. Global Top Shingles Treatments Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Shingles Treatments as of 2019)
Table 21. Global Shingles Treatments by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Shingles Treatments Product Solution and Service
Table 24. Date of Enter into Shingles Treatments Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Shingles Treatments Market Size by Type (2015-2020) (Million US$)
Table 27. Global Shingles Treatments Market Size Share by Type (2015-2020)
Table 28. Global Shingles Treatments Revenue Market Share by Type (2021-2026)
Table 29. Global Shingles Treatments Market Size Share by Application (2015-2020)
Table 30. Global Shingles Treatments Market Size by Application (2015-2020) (Million US$)
Table 31. Global Shingles Treatments Market Size Share by Application (2021-2026)
Table 32. North America Key Players Shingles Treatments Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Shingles Treatments Market Share (2019-2020)
Table 34. North America Shingles Treatments Market Size by Type (2015-2020) (Million US$)
Table 35. North America Shingles Treatments Market Share by Type (2015-2020)
Table 36. North America Shingles Treatments Market Size by Application (2015-2020) (Million US$)
Table 37. North America Shingles Treatments Market Share by Application (2015-2020)
Table 38. Europe Key Players Shingles Treatments Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Shingles Treatments Market Share (2019-2020)
Table 40. Europe Shingles Treatments Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Shingles Treatments Market Share by Type (2015-2020)
Table 42. Europe Shingles Treatments Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Shingles Treatments Market Share by Application (2015-2020)
Table 44. China Key Players Shingles Treatments Revenue (2019-2020) (Million US$)
Table 45. China Key Players Shingles Treatments Market Share (2019-2020)
Table 46. China Shingles Treatments Market Size by Type (2015-2020) (Million US$)
Table 47. China Shingles Treatments Market Share by Type (2015-2020)
Table 48. China Shingles Treatments Market Size by Application (2015-2020) (Million US$)
Table 49. China Shingles Treatments Market Share by Application (2015-2020)
Table 50. Japan Key Players Shingles Treatments Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Shingles Treatments Market Share (2019-2020)
Table 52. Japan Shingles Treatments Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Shingles Treatments Market Share by Type (2015-2020)
Table 54. Japan Shingles Treatments Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Shingles Treatments Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Shingles Treatments Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Shingles Treatments Market Share (2019-2020)
Table 58. Southeast Asia Shingles Treatments Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Shingles Treatments Market Share by Type (2015-2020)
Table 60. Southeast Asia Shingles Treatments Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Shingles Treatments Market Share by Application (2015-2020)
Table 62. India Key Players Shingles Treatments Revenue (2019-2020) (Million US$)
Table 63. India Key Players Shingles Treatments Market Share (2019-2020)
Table 64. India Shingles Treatments Market Size by Type (2015-2020) (Million US$)
Table 65. India Shingles Treatments Market Share by Type (2015-2020)
Table 66. India Shingles Treatments Market Size by Application (2015-2020) (Million US$)
Table 67. India Shingles Treatments Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Shingles Treatments Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Shingles Treatments Market Share (2019-2020)
Table 70. Central & South America Shingles Treatments Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Shingles Treatments Market Share by Type (2015-2020)
Table 72. Central & South America Shingles Treatments Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Shingles Treatments Market Share by Application (2015-2020)
Table 74. Astellas Pharma Company Details
Table 75. Astellas Pharma Business Overview
Table 76. Astellas Pharma Product
Table 77. Astellas Pharma Revenue in Shingles Treatments Business (2015-2020) (Million US$)
Table 78. Astellas Pharma Recent Development
Table 79. Foamix Company Details
Table 80. Foamix Business Overview
Table 81. Foamix Product
Table 82. Foamix Revenue in Shingles Treatments Business (2015-2020) (Million US$)
Table 83. Foamix Recent Development
Table 84. Novartis Company Details
Table 85. Novartis Business Overview
Table 86. Novartis Product
Table 87. Novartis Revenue in Shingles Treatments Business (2015-2020) (Million US$)
Table 88. Novartis Recent Development
Table 89. Roche Company Details
Table 90. Roche Business Overview
Table 91. Roche Product
Table 92. Roche Revenue in Shingles Treatments Business (2015-2020) (Million US$)
Table 93. Roche Recent Development
Table 94. GlaxoSmithKline Company Details
Table 95. GlaxoSmithKline Business Overview
Table 96. GlaxoSmithKline Product
Table 97. GlaxoSmithKline Revenue in Shingles Treatments Business (2015-2020) (Million US$)
Table 98. GlaxoSmithKline Recent Development
Table 99. Epiphany Biosciences Company Details
Table 100. Epiphany Biosciences Business Overview
Table 101. Epiphany Biosciences Product
Table 102. Epiphany Biosciences Revenue in Shingles Treatments Business (2015-2020) (Million US$)
Table 103. Epiphany Biosciences Recent Development
Table 104. Merck Company Details
Table 105. Merck Business Overview
Table 106. Merck Product
Table 107. Merck Revenue in Shingles Treatments Business (2015-2020) (Million US$)
Table 108. Merck Recent Development
Table 109. Beijing Minhai Biotechnology Business Overview
Table 110. Beijing Minhai Biotechnology Product
Table 111. Beijing Minhai Biotechnology Company Details
Table 112. Beijing Minhai Biotechnology Revenue in Shingles Treatments Business (2015-2020) (Million US$)
Table 113. Beijing Minhai Biotechnology Recent Development
Table 114. GeneOne Life Science Company Details
Table 115. GeneOne Life Science Business Overview
Table 116. GeneOne Life Science Product
Table 117. GeneOne Life Science Revenue in Shingles Treatments Business (2015-2020) (Million US$)
Table 118. GeneOne Life Science Recent Development
Table 119. NAL Pharmaceuticals Company Details
Table 120. NAL Pharmaceuticals Business Overview
Table 121. NAL Pharmaceuticals Product
Table 122. NAL Pharmaceuticals Revenue in Shingles Treatments Business (2015-2020) (Million US$)
Table 123. NAL Pharmaceuticals Recent Development
Table 124. TSRL Company Details
Table 125. TSRL Business Overview
Table 126. TSRL Product
Table 127. TSRL Revenue in Shingles Treatments Business (2015-2020) (Million US$)
Table 128. TSRL Recent Development
Table 129. Research Programs/Design for This Report
Table 130. Key Data Information from Secondary Sources
Table 131. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Shingles Treatments Market Share by Type: 2020 VS 2026
Figure 2. Oral Features
Figure 3. Tablets Features
Figure 4. Global Shingles Treatments Market Share by Application: 2020 VS 2026
Figure 5. Clinics Case Studies
Figure 6. Hospitals Case Studies
Figure 7. Diagnostic Centres Case Studies
Figure 8. Home Care Settings Case Studies
Figure 9. Shingles Treatments Report Years Considered
Figure 10. Global Shingles Treatments Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Shingles Treatments Market Share by Regions: 2020 VS 2026
Figure 12. Global Shingles Treatments Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Shingles Treatments Market Share by Players in 2019
Figure 15. Global Top Shingles Treatments Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Shingles Treatments as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Shingles Treatments Revenue in 2019
Figure 17. North America Shingles Treatments Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Shingles Treatments Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Shingles Treatments Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Shingles Treatments Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Shingles Treatments Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Shingles Treatments Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Shingles Treatments Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed
発作治療の世界市場（～2026年） An epileptic seizure is a brief episode of signs or symptoms due to abnormally excessive or synchronous neuronal activity in the brain. Increasing prevalence of neurological disorders is expected to be the dominant factor driving the global seize treatment market over the forecast period. Market Ana…- 瘢痕併用療法の世界市場（～2026年） Scar treatment is a technique that is utilized to limit the scars marks so that it seem more consistent with the skin tone and surface surrounding. Scars are marks that stay after a wound recovers and unavoidable aftereffects of damage or surgery. Scars are of different types, which includes keloid …
- 統合失調症治療の世界市場（～2026年） Schizophrenia is a mental disorder characterized by abnormal behavior and failure to understand reality. The schizophrenia treatment market is expected to witness a high growth over the forecast period owing to the increasing incidence of schizophrenia. Market Analysis and Insights: Global Schizophr…
- 脳腫瘍診断・治療の世界市場（～2026年） With the increasing prevalence of brain cancer, rising aging population, and growing incidences of cancer via chemical exposure, the demand of Diagnosis and treatment of brain tumors is increasing. Market Analysis and Insights: Global Brain Tumor Diagnosis and Treatments Market The global Brain Tumo…
- 薬物アレルギー治療/治療薬の世界市場（～2026年） Market Analysis and Insights: Global Drug Allergy Treatments and Drugs Market The global Drug Allergy Treatments and Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Drug Allergy Treatments and Drugs Scope and Mar…